Comparison of the physiological relevance of systemic vs. Portal insulin delivery to evaluate whole body glucose flux during an insulin clamp

American Journal of Physiology - Endocrinology and Metabolism

Volumn 308, Issue 3, 2015, Pages E206-E222

  Farmer, Tiffany D ^a   Jenkins, Erin C ^a   O’Brien, Tracy P ^a   McCoy, Gregory A ^a   Havlik, Allison E ^a   Nass, Erik R ^a   Nicholson, Wendell E ^a   Printz, Richard L ^a   Shiota, Masakazu ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Insulin clamp method; Liver; Muscle; Portal systemic insulin gradient

Indexed keywords

GLUCOSE; GLYCOGEN; INSULIN; RECOMBINANT HUMAN INSULIN; SOMATOSTATIN; GLUCAGON; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ARTERIAL CIRCULATION; ARTICLE; CLAMP; COMPARATIVE STUDY; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; GLYCOGEN LIVER LEVEL; GLYCOGEN MUSCLE LEVEL; INSULIN INFUSION; INSULIN RELEASE; MALE; NONHUMAN; PORTAL VEIN BLOOD FLOW; PRIORITY JOURNAL; RAT; ANIMAL; BLOOD; CATHETERIZATION; EVALUATION STUDY; GLUCOSE CLAMP TECHNIQUE; HYPERGLYCEMIA; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; PORTAL VEIN; PROCEDURES; SECRETION (PROCESS); SPRAGUE DAWLEY RAT;

ADMINISTRATION, INTRAVENOUS; ANIMALS; BLOOD GLUCOSE; CATHETERIZATION, PERIPHERAL; GLUCAGON; GLUCOSE CLAMP TECHNIQUE; HYPERGLYCEMIA; INSULIN; MALE; PORTAL VEIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84922031936     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00406.2014     Document Type: Article

References (96)

1. Ayala JE, Bracy DP, McGuinness OP, Wasserman DH. Considerations in the design of hyperinsulinemic-euglycemic clamps in the conscious mouse. Diabetes 55: 390–397, 2006.
2. Ayesha I, Bala TS, Reddy CV, Raghuramulu N. Vitamin D deficiency reduces insulin secretion and turnover in rats. Diabetes Nutr Metab 14: 78–84, 2001.
3. Balage M, Grizard J. Relationship between plasma glucagon disappearance and tissue uptake in rats. Reprod Nutr Dev 26: 31–38, 1986.
4. Bansal P, Wang Q. Insulin as a physiological modulator of glucagon secretion. Am J Physiol Endocrinol Metab 295: E751–E761, 2008.
5. Berglund ED, Vianna CR, Donato J Jr, Kim MH, Chuang JC, Lee CE, Lauzon DA, Lin P, Brule LJ, Scott MM, Coppari R, Elmquist JK. Direct leptin action on POMC neurons regulates glucose homeostasis and hepatic insulin sensitivity in mice. J Clin Invest 122: 1000–1009, 2012.
6. Bergman RN. Non-esterified fatty acids and the liver: Why is insulin secreted into the portal vein? Diabetologia 43: 946–952, 2000.
7. Blackard WG, Nelson NC, Andrews SS. Portal and peripheral vein immunoreactive glucagon concentrations after arginine or glucose infusions. Diabetes 23: 199–202, 1974.
8. Bonner JS, Lantier L, Hocking KM, Kang L, Owolabi M, James FD, Bracy DP, Brophy CM, Wasserman DH. Relaxin treatment reverses insulin resistance in mice fed a high-fat diet. Diabetes 62: 3251–3260, 2013.
9. Bonora E, Zavaroni I, Coscelli C, Butturini U. Decreased hepatic insulin extraction in subjects with mild glucose intolerance. Metabolism 32: 438–446, 1983.
10. Brandimarti P, Costa-Junior JM, Ferreira SM, Protzek AO, Santos GJ, Carneiro EM, Boschero AC, Rezende LF. Cafeteria diet inhibits insulin clearance by reduced insulin-degrading enzyme expression and mRNA splicing. J Endocrinol 219: 173–182, 2013.
11. Canas X, Fernandez-Lopez JA, Ardevol A, Adan C, Esteve M, Rafecas I, Remesar X, Alemany M. Rat insulin turnover in vivo. Endocrinology 136: 3871–3876, 1995.
12. Canavan JP, Flecknell PA, New JP, Alberti KG, Home PD. The effect of portal and peripheral insulin delivery on carbohydrate and lipid metabolism in a miniature pig model of human IDDM. Diabetologia 40: 1125–1134, 1997.
13. Carlisle KM, Halliwell M, Read AE, Wells PN. Estimation of total hepatic blood flow by duplex ultrasound. Gut 33: 92–97, 1992.
14. Chu CA, Fujimoto Y, Igawa K, Grimsby J, Grippo JF, Magnuson MA, Cherrington AD, Shiota M. Rapid translocation of hepatic glucokinase in response to intraduodenal glucose infusion and changes in plasma glucose and insulin in conscious rats. Am J Physiol Gastrointest Liver Physiol 286: G627–G634, 2004.
15. Cobelli C, Pacini G. Insulin secretion and hepatic extraction in humans by minimal modeling of C-peptide and insulin kinetics. Diabetes 37: 223–231, 1988.
16. Cresto JC, Lavine RL, Buchly ML, Penhos JC, Bhathena SJ, Recant L. Half life of injected 125I-insulin in control and ob/ob mice. Acta Physiol Lat Am 27: 7–15, 1977.
17. Deacon CF, Kelstrup M, Trebbien R, Klarskov L, Olesen M, Holst JJ. Differential regional metabolism of glucagon in anesthetized pigs. Am J Physiol Endocrinol Metab 285: E552–E560, 2003.
18. DeFronzo RA, Bonadonna RC, Ferrannini E. Pathogenesis of NIDDM. A balanced overview. Diabetes Care 15: 318–368, 1992.
19. DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol Endocrinol Metab Gastrointest Physiol 237: E214–E223, 1979.
20. Duckworth WC, Bennett RG, Hamel FG. Insulin degradation: progress and potential. Endocr Rev 19: 608–624, 1998.
21. Eaton RP, Allen RC, Schade DS. Hepatic removal of insulin in normal man: dose response to endogenous insulin secretion. J Clin Endocrinol Metab 56: 1294–1300, 1983.
22. Faber OK, Christensen K, Kehlet H, Madsbad S, Binder C. Decreased insulin removal contributes to hyperinsulinemia in obesity. J Clin Endocrinol Metab 53: 618–621, 1981.
23. Fernandez-Lopez JA, Casado J, Argiles JM, Alemany M. Intestinal handling of a glucose gavage by the rat. Mol Cell Biochem 113: 43–53, 1992.
24. Finegood DT, Bergman RN. Optimal segments: a method for smoothing tracer data to calculate metabolic fluxes. Am J Physiol Endocrinol Metab 244: E472–E479, 1983.
25. Flattem N, Igawa K, Shiota M, Emshwiller MG, Neal DW, Cherrington AD. Alpha- and beta-cell responses to small changes in plasma glucose in the conscious dog. Diabetes 50: 367–375, 2001.
26. Fujimoto Y, Donahue EP, Shiota M. Defect in glucokinase translocation in Zucker diabetic fatty rats. Am J Physiol Endocrinol Metab 287: E414–E423, 2004.
27. Fujimoto Y, Torres TP, Donahue EP, Shiota M. Glucose toxicity is responsible for the development of impaired regulation of endogenous glucose production and hepatic glucokinase in Zucker diabetic fatty rats. Diabetes 55: 2479–2490, 2006.
28. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI. Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 48: 1270–1274, 1999.
29. Gromada J, Duttaroy A, Rorsman P. The insulin receptor talks to glucagon? Cell Metab 9: 303–305, 2009.
30. Harding PE, Bloom G, Field JB. Effect of infusion of insulin into portal vein on hepatic extraction of insulin in anesthetized dogs. Am J Physiol 228: 1580–1588, 1975.
31. He W, Lam TK, Obici S, Rossetti L. Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat Neurosci 9: 227–233, 2006.
32. Hennes MM, Shrago E, Kissebah AH. Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obesity 14: 831–841, 1990.
33. Hevener AL, He W, Barak Y, Le J, Bandyopadhyay G, Olson P, Wilkes J, Evans RM, Olefsky J. Muscle-specific Pparg deletion causes insulin resistance. Nat Med 9: 1491–1497, 2003.
34. Hollingdal M, Juhl CB, Pincus SM, Sturis J, Veldhuis JD, Polonsky KS, Porksen N, Schmitz O. Failure of physiological plasma glucose excursions to entrain high-frequency pulsatile insulin secretion in type 2 diabetes. Diabetes 49: 1334–1340, 2000.
35. Igawa K, Mugavero M, Shiota M, Neal DW, Cherrington AD. Insulin sensitively controls the glucagon response to mild hypoglycemia in the dog. Diabetes 51: 3033–3042, 2002.
36. Jaspan J, Polonsky K. Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin. J Clin Invest69: 516–525, 1982.
37. Jaspan JB, Polonsky KS, Lewis M, Pensler J, Pugh W, Moossa AR, Rubenstein AH. Hepatic metabolism of glucagon in the dog: contribution of the liver to overall metabolic disposal of glucagon. Am J Physiol Endocrinol Metab 240: E233–E244, 1981.
38. Jones RG, Ilic V, Williamson DH. Physiological significance of altered insulin metabolism in the conscious rat during lactation. Biochem J 220: 455–460, 1984.
39. Kaden M, Harding P, Field JB. Effect of intraduodenal glucose administration on hepatic extraction of insulin in the anesthetized dog. J Clin Invest 52: 2016–2028, 1973.
40. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402–2410, 2000.
41. Kawamori D, Kurpad AJ, Hu J, Liew CW, Shih JL, Ford EL, Herrera PL, Polonsky KS, McGuinness OP, Kulkarni RN. Insulin signaling in alpha cells modulates glucagon secretion in vivo. Cell Metab 9: 350–361, 2009.
42. Kim JK. Hyperinsulinemic-euglycemic clamp to assess insulin sensitivity in vivo. Methods Mol Biol 560: 221–238, 2009.
43. Kim SP, Ellmerer M, Kirkman EL, Bergman RN. Beta-cell “rest” accompanies reduced first-pass hepatic insulin extraction in the insulinresistant, fat-fed canine model. Am J Physiol Endocrinol Metab 292: E1581–E1589, 2007.
44. Kokorovic A, Cheung GW, Rossetti L, Lam TK. Hypothalamic sensing of circulating lactate regulates glucose production. J Cell Mol Med 13: 4403–4408, 2009.
45. Laedtke T, Kjems L, Porksen N, Schmitz O, Veldhuis J, Kao PC, Butler PC. Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. Am J Physiol Endocrinol Metab 279: E520–E528, 2000.
46. Lamontagne J, Jalbert-Arsenault E, Pepin E, Peyot ML, Ruderman NB, Nolan CJ, Joly E, Madiraju SR, Poitout V, Prentki M. Pioglitazone acutely reduces energy metabolism and insulin secretion in rats. Diabetes 62: 2122–2129, 2013.
47. Lang DA, Matthews DR, Burnett M, Turner RC. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man. Diabetes 30: 435–439, 1981.
48. Lang V, Vaugelade P, Bernard F, Darcy-Vrillon B, Alamowitch C, Slama G, Duee PH, Bornet FR. Euglycemic hyperinsulinemic clamp to assess posthepatic glucose appearance after carbohydrate loading. 1. Validation in pigs. Am J Clin Nutr 69: 1174–1182, 1999.
49. Lee SS, Girod C, Valla D, Geoffroy P, Lebrec D. Effects of pentobarbital sodium anesthesia on splanchnic hemodynamics of normal and portal-hypertensive rats. Am J Physiol Gastrointest Liver Physiol 249:G528–G532, 1985.
50. Leibiger IB, Leibiger B, Berggren PO. Insulin feedback action on pancreatic beta-cell function. FEBS Lett 532: 1–6, 2002.
51. Leibiger IB, Leibiger B, Berggren PO. Insulin signaling in the pancreatic beta-cell. Annu Rev Nutr 28: 233–251, 2008.
52. Levin BE, Sherwin RS. Peripheral glucose homeostasis: does brain insulin matter? J Clin Invest 121: 3392–3395, 2011.
53. Levitt NS, Hirsch L, Rubenstein AH, Polonsky KS. Quantitative evaluation of the effect of low-intensity exercise on insulin secretion in man. Metabolism 42: 829–833, 1993.
54. Ma K, Cabrero A, Saha PK, Kojima H, Li L, Chang BH, Paul A, Chan L. Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin. J Biol Chem 277: 34658–34661, 2002.
55. Magkos F, Fabbrini E, Patterson BW, Eagon JC, Klein S. Portal vein and systemic adiponectin concentrations are closely linked with hepatic glucose and lipoprotein kinetics in extremely obese subjects. Metabolism 60: 1641–1648, 2011.
56. Malik AB, Kaplan JE, Saba TM. Reference sample method for cardiac output and regional blood flow determinations in the rat. J Appl Physiol 40: 472–475, 1976.
57. Matthews DR, Rudenski AS, Burnett MA, Darling P, Turner RC. The half-life of endogenous insulin and C-peptide in man assessed by somatostatin suppression. Clin Endocrinol (Oxf) 23: 71–79, 1985.
58. Matveyenko AV, Liuwantara D, Gurlo T, Kirakossian D, Dalla Man C, Cobelli C, White MF, Copps KD, Volpi E, Fujita S, Butler PC. Pulsatile portal vein insulin delivery enhances hepatic insulin action and signaling. Diabetes 61: 2269–2279, 2012.
59. Matveyenko AV, Veldhuis JD, Butler PC. Measurement of pulsatile insulin secretion in the rat: direct sampling from the hepatic portal vein. Am J Physiol Endocrinol Metab 295: E569–E574, 2008.
60. Matveyenko AV, Veldhuis JD, Butler PC. Mechanisms of impaired fasting glucose and glucose intolerance induced by an approximate 50% pancreatectomy. Diabetes 55: 2347–2356, 2006.
61. McMahon MM, Schwenk WF, Haymond MW, Rizza RA. Underestimation of glucose turnover measured with [6 –3H]- and [6,6 –2H]- but not [6 –14C]glucose during hyperinsulinemia in humans. Diabetes 38: 97–107, 1989.
62. Meier JJ, Veldhuis JD, Butler PC. Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. Diabetes 54: 1649–1656, 2005.
63. Meistas MT, Rendell M, Margolis S, Kowarski AA. Estimation of the secretion rate of insulin from the urinary excretion rate of C-peptide. Study in obese and diabetic subjects. Diabetes 31: 449–453, 1982.
64. Monti LD, Piatti PM, Home PD, Tomson C, Alberti KG. The effect of intraperitoneal insulin delivery on carbohydrate metabolism in type 1 (insulin-dependent) diabetic patients. Diabetes Res Clin Pract 15: 237–244, 1992.
65. Muse ED, Lam TK, Scherer PE, Rossetti L. Hypothalamic resistin induces hepatic insulin resistance. J Clin Invest 117: 1670–1678, 2007.
66. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor gamma agonists. J Biol Chem 281: 2654–2660, 2006.
67. Okamoto H, Obici S, Accili D, Rossetti L. Restoration of liver insulin signaling in Insr knockout mice fails to normalize hepatic insulin action. J Clin Invest 115: 1314–1322, 2005.
68. Polonsky KS, Given BD, Hirsch L, Shapiro ET, Tillil H, Beebe C, Galloway JA, Frank BH, Karrison T, Van Cauter E. Quantitative study of insulin secretion and clearance in normal and obese subjects. J Clin Invest 81: 435–441, 1988.
69. Polonsky KS, Rubenstein AH. C-peptide as a measure of the secretion and hepatic extraction of insulin. Pitfalls and limitations. Diabetes 33: 486–494, 1984.
70. Pontiroli AE, Calderara A, Perfetti MG, Bareggi SR. Pharmacokinetics of intranasal, intramuscular and intravenous glucagon in healthy subjects and diabetic patients. Eur J Clin Pharmacol 45: 555–558, 1993.
71. Porksen N, Munn S, Steers J, Veldhuis JD, Butler PC. Effects of glucose ingestion versus infusion on pulsatile insulin secretion. The incretin effect is achieved by amplification of insulin secretory burst mass. Diabetes 45: 1317–1323, 1996.
72. Porksen N, Munn S, Steers J, Vore S, Veldhuis J, Butler P. Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting. Am J Physiol Endocrinol Metab 269: E478–E488, 1995.
73. Porksen N, Munn SR, Steers JL, Veldhuis JD, Butler PC. Effects of somatostatin on pulsatile insulin secretion: elective inhibition of insulin burst mass. Am J Physiol Endocrinol Metab 270: E1043–E1049, 1996.
74. Rizza RA, Mandarino LJ, Gerich JE. Dose-response characteristics for effects of insulin on production and utilization of glucose in man. Am J Physiol Endocrinol Metab 240: E630–E639, 1981.
75. Rossell R, Gomis R, Casamitjana R, Segura R, Vilardell E, Rivera F. Reduced hepatic insulin extraction in obesity: Relationship with plasma insulin levels. J Clin Endocrinol Metab 56: 608–611, 1983.
76. Sasaki Y, Wagner HN Jr. Measurement of the distribution of cardiac output in unanesthetized rats. J Appl Physiol 30: 879–884, 1971.
77. Sekigami T, Shimoda S, Nishida K, Matsuo Y, Ichimori S, Ichinose K, Shichiri M, Sakakida M, Araki E. Comparison between closed-loop portal and peripheral venous insulin delivery systems for an artificial endocrine pancreas. J Artificial Organs 7: 91–100, 2004.
78. Shin JS, Torres TP, Catlin RL, Donahue EP, Shiota M. A defect in glucose-induced dissociation of glucokinase from the regulatory protein in Zucker diabetic fatty rats in the early stage of diabetes. Am J Physiol Regul Integr Comp Physiol 292: R1381–R1390, 2007.
79. Shiota M. Measurement of glucose homeostasis in vivo: combination of tracers and clamp techniques. Methods Mol Biol 933: 229–253, 2012.
80. Shiota M, Jackson PA, Bischoff H, McCaleb M, Scott M, Monohan M, Neal DW, Cherrington AD. Inhibition of glycogenolysis enhances gluconeogenic precursor uptake by the liver of conscious dogs. Am J Physiol Endocrinol Metab 273: E868–E879, 1997.
81. Shiota M, Moore MC, Galassetti P, Monohan M, Neal DW, Shulman GI, Cherrington AD. Inclusion of low amounts of fructose with an intraduodenal glucose load markedly reduces postprandial hyperglycemia and hyperinsulinemia in the conscious dog. Diabetes 51: 469–478, 2002.
82. Shoelson SE, Polonsky KS, Zeidler A, Rubenstein AH, Tager HS. Human insulin B24 (Phe–Ser). Secretion and metabolic clearance of the abnormal insulin in man and in a dog model. J Clin Invest 73: 1351–1358, 1984.
83. Smith D, Rossetti L, Ferrannini E, Johnson CM, Cobelli C, Toffolo G, Katz LD, DeFronzo RA. In vivo glucose metabolism in the awake rat: Tracer and insulin clamp studies. Metabolism 36: 1167–1174, 1987.
84. Sodoyez JC, Sodoyez-Goffaux F, Guillaume M, Merchie G. [123I]Insulin metabolism in normal rats and humans: External detection by a scintillation camera. Science 219: 865–867, 1983.
85. Song SH, McIntyre SS, Shah H, Veldhuis JD, Hayes PC, Butler PC. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects. J Clin Endocrinol Metab 85: 4491–4499, 2000.
86. Stromblad G, Bjorntorp P. Reduced hepatic insulin clearance in rats with dietary-induced obesity. Metabolism 35: 323–327, 1986.
87. Svedberg J, Bjorntorp P, Smith U, Lonnroth P. Free-fatty acid inhibition of insulin binding, degradation, and action in isolated rat hepatocytes. Diabetes 39: 570–574, 1990.
88. Torres TP, Catlin RL, Chan R, Fujimoto Y, Sasaki N, Printz RL, Newgard CB, Shiota M. Restoration of hepatic glucokinase expression corrects hepatic glucose flux and normalizes plasma glucose in zucker diabetic fatty rats. Diabetes 58: 78–86, 2009.
89. Torres TP, Fujimoto Y, Donahue EP, Printz RL, Houseknecht KL, Treadway JL, Shiota M. Defective glycogenesis contributes toward the inability to suppress hepatic glucose production in response to hyperglycemia and hyperinsulinemia in zucker diabetic fatty rats. Diabetes 60: 2225–2233, 2011.
90. Torres TP, Sasaki N, Donahue EP, Lacy B, Printz RL, Cherrington AD, Treadway JL, Shiota M. Impact of a glycogen phosphorylase inhibitor and metformin on basal and glucagon-stimulated hepatic glucose flux in conscious dogs. J Pharmacol Exp Ther 337: 610–620, 2011.
91. Valera Mora ME, Scarfone A, Calvani M, Greco AV, Mingrone G. Insulin clearance in obesity. J Am Coll Nutr 22: 487–493, 2003.
92. Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 89: 1269–1339, 2009.
93. Waldhausl W, Bratusch-Marrain P, Gasic S, Korn A, Nowotny P. Insulin production rate following glucose ingestion estimated by splanchnic C-peptide output in normal man. Diabetologia 17: 221–227, 1979.
94. Wang CC, Adochio RL, Leitner JW, Abeyta IM, Draznin B, Cornier MA. Acute effects of different diet compositions on skeletal muscle insulin signalling in obese individuals during caloric restriction. Metabolism 62: 595–603, 2013.
95. Wang L, Shao J, Muhlenkamp P, Liu S, Klepcyk P, Ren J, Friedman JE. Increased insulin receptor substrate-1 and enhanced skeletal muscle insulin sensitivity in mice lacking CCAAT/enhancer-binding protein beta. J Biol Chem 275: 14173–14181, 2000.
96. Wiesenthal SR, Sandhu H, McCall RH, Tchipashvili V, Yoshii H, Polonsky K, Shi ZQ, Lewis GF, Mari A, Giacca A. Free fatty acids impair hepatic insulin extraction in vivo. Diabetes 48: 766–774, 1999.